Establishment of the Facilitating Council to strengthen global collaborationenbspnbsp
VietReader 13-09-2020, 00:05

Establishment of the Facilitating Council to strengthen global collaborationenbspnbsp

The ACT accelerator aims to ensure equitable access to tests, treatments and vaccines for all countries. Photo: Vingroup /CVN

The creation of this device will contribute to the development and equitable distribution of vaccines and technologies in response to COVID-19 said Ambassador Le Thi Tuyet Mai, head of the Permanent Mission of Vietnam to the UN, WTO and other international organizations in Geneva.
At the first council meeting on September 10 the Vietnamese diplomat thanked WHO and the European Mission for inviting Vietnam to attend the event as ASEAN President in 2020.
She highlighted the recent efforts of ASEAN and Vietnam in response to COVID-19 and affirmed the commitments of member states to strengthen international solidarity and cooperation to fight the pandemic, in particular the activities of the Facilitating Council. of ACT to promote equitable access to vaccines and COVID-19 response tools and post-pandemic recovery.
European Commission President Ursula von der Leyen and WHO Director-General Tedros Adhanom Ghebreyesus on September 10 opened the first co-organized meeting of the High-Level Facilitation Council, which is leading the work of the collaborative framework worldwide, the ACT Accelerator, aimed at accelerating the development and deployment of COVID-19 vaccines, tests and treatments, as well as improving health systems.
The objective of this first meeting was to adapt the mechanism relating to the ACT accelerator as a decisive global solution to end the crisis, restore health systems, revive global growth, agree on the economic logic and the investment case to fully fund the ACT accelerator, and mobilize political leaders and international support for equitable global distribution.
At its first meeting, the Facilitating Council adopted a political declaration stressing that global collaboration is essential to defeat the virus. This statement highlights the importance of testing, treatment, immunization and improving health systems to overcome the pandemic. It also mentions the progress made and calls for the provision of additional resources to carry out the mission.
The Facilitation Board is made up of leaders from governments and non-government partners (BMGF, Wellcome Trust). It is co-chaired by Norway and South Africa, thus ensuring a good geographical balance. The Facilitating Council builds on the results obtained by the ACT accelerator in just four months, with more than 200 vaccine candidates, 1700 clinical trials and 80 diagnoses followed, as well as surveys carried out in 100 countries to identify capacity gaps.
Next steps
Concluding observations on the investment case and the mechanism to accelerate access to tools to fight COVID-19 will be presented on September 17 followed by the high-level meeting on the ACT accelerator at the General Assembly of Nations. United (UNGA) will be held on September 30.
Between September 15 and 30 meetings of the UNGA and the G20 will be organized, which will amplify the appeal to world leaders. Between October 12 and 18 annual meetings of the World Bank and IMF will be held to review the scale of the economic challenge and the initial commitments. From November to March 2021 the G20 summit and other related meetings will respond to this set of commitments.
Finally, the awareness campaign on the ACT Accelerator aims to address key policy challenges and meet funding needs of over 29 billion euros (35 billion USD).

Malaysians wear protective masks on the street in Kuala Lumpur (Malaysia). Photo: Xinhua /VNA /CVN


Set up at the end of April 2020 the ACT accelerator brings together leaders of governments, scientists, companies, civil society, philanthropists and global organizations working in the field of health (FoundationBill & Melinda Gates, CEPI, FIND , Gavi, the Global Fund, Unitaid, Wellcome, the WHO, the World Bank and Global Financing Facility). It aims to accelerate the development of vaccines, treatments and diagnostic tools accessible to all, as well as the improvement of the necessary health systems. Sharing knowledge and data is essential. The ACT accelerator will be in place for a period of two years (renewable). No new physical structure will be created, but the expertise of existing institutions and partners will be brought up to profit.https: // .
Three partnerships on vaccines, treatments and diagnostic tools define the strategy, determine the necessary resources and set the rules for accountability. They bring together industry, research, foundations, regulators and international organizations, following a value chain approach, from research to manufacturing and deployment. These partnerships operate as autonomously as possible and are supported by a group of government and private not-for-profit partners.
The ACT Accelerator aims to protect health systems, restore societies and revive economies by accelerating the development, equitable distribution and scaling up of two billion doses of vaccine by the end of 2021245 million treatments by mid-2021 and 500 million tests by mid-2021.
The European Commission is committed to finding a global solution to the pandemic. Since May 42020 the Commission has thus raised nearly 16 billion euros as part of the global response to the coronavirus, global action for universal access to tests, treatments and vaccines against the coronavirus as well as for the global revival.